NAMS
NewAmsterdam Pharma Company N.V. has filed 386 documents with the SEC between 2022 and 2026. The most frequent type is insider trade (101 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Proxy statement | DEF 14A | 2026-05-06 | 2026-05-06 |
| Proxy statement | DEF 14A | 2025-05-08 | 2025-06-04 |
| Proxy statement | DEF 14A | 2024-05-09 | 2024-06-05 |